| Financial Year |
March 31 2023 |
| Monetary Funds |
2,580,167,008.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
224,468,589.13 |
| Advances to Suppliers |
153,487,704.64 |
| Other Receivables |
594,290,300.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,987,136,330.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
195,400,577.41 |
| Total Current Assets |
5,748,735,488.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
322,621,882.20 |
| Long-term Equity Investment |
264,984,740.28 |
| Investment Properties |
50,936,906.49 |
| Fixed Assetes |
214,911,050.24 |
| Under-construction Projects |
128,783,967.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
28,050,564.69 |
| R&D expenses |
-- |
| Goodwill |
36,294,703.21 |
| Long-Term Deferred and Prepaid Expenses |
35,035,715.43 |
| Deferred Income Tax Assets |
165,594,629.65 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,376,049,986.74 |
| Total Assets |
7,124,785,474.99 |
| Short-Term Loans |
20,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
307,886,694.79 |
| Accounts Received In Advance |
10,992,053.89 |
| Employee Compensation Payable |
63,052,712.97 |
| Taxes Payable |
24,618,561.62 |
| Interest Payable |
-- |
| Dividend Payable |
8,256,958.42 |
| Other payables |
421,775,561.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
130,530,610.33 |
| Other Current Liabilities |
185,626,753.69 |
| Sub-Total of Current Liabilities |
3,501,605,120.97 |
| Long-term Loans |
161,263,722.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
22,424,868.97 |
| Deferred Income Tax Liabilities |
33,602,319.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
292,303,706.55 |
| Total Liabilities |
3,793,908,827.52 |
| Paid-In Capital(Or Share Stock) |
959,513,067.00 |
| Capital Surplus |
94,509,155.03 |
| Surplus Reserve |
145,954,471.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,263,980,982.01 |
| Minority Stockholder's Interest |
852,408,909.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,478,467,737.76 |
| Owner's Equity（Stockholder's Equity） |
3,330,876,647.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,124,785,474.99 |
